TrialThe lancet. Diabetes & endocrinology2016

Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.

Juan P Frías et al.PubMed ↗Publisher ↗

No numbers read from the abstract.